Depression: Conference Sessions

MGH 50th Annual Psychopharmacology Conference

October 16–18, 2026 · Boston, MA

• LecturePharmacology of Antidepressant Drugs

  Frank Tarazi

  Covers the pharmacology of antidepressant drugs, including how they act and how their properties differ.

  Neuroscience & Mechanisms

• LectureCourse and Treatment of Mood/Anxiety During Pregnancy

  Lee S. Cohen

  How mood and anxiety disorders behave during pregnancy and how to treat them safely.

  Anxiety DisordersPerinatal & Women's Mental Health

• LecturePostpartum Mood and Anxiety Disorders

  Marlene P. Freeman

  Recognition and treatment of depression and anxiety in the postpartum period.

  Anxiety DisordersPerinatal & Women's Mental Health

• PanelPanel Discussion

  Jerrold F. Rosenbaum · Andrew A. Nierenberg · Roy Perlis · Maurizio Fava

  Faculty discussion on mood disorder topics from the module.

  Bipolar Disorder

• WorkshopPMDD and Depression During the Menopausal Transition: New Insights

  Laura Fagioli Petrillo

  Evening seminar on PMDD and depression in the menopausal transition.

  Perinatal & Women's Mental Health

See all 8 depression sessions at this meeting →

MasterPsych Psychiatry Conference 2026

October 19–22, 2026 · Newport Beach, CA

• LectureDepression in the Elderly

  Jason Jalil

  Discusses depression in older adults.

  Geriatric

AACAP Annual Meeting 2026

October 26–31, 2026 · Atlanta, GA

• LectureUnderstanding the Natural Landscape of the Chronology of MDD and Mania in Youth: Findings From an ASD-Enriched Sample

  Mai Uchida

  Presents findings on the timing and sequence of major depression and mania in youth in an autism-enriched sample.

  Autism & Neurodevelopmental DisordersBipolar DisorderChild & Adolescent

• LectureMDD in Youth With and Without Autism: Psychiatric Comorbidity and Functional Outcomes

  Usman Ghumman

  Compares psychiatric comorbidity and functional outcomes of major depression in youth with and without autism.

  Autism & Neurodevelopmental DisordersChild & Adolescent

• LectureThe Intersection of Neurodiversity and Gender Variance: Compounding Risks for Depression and Suicide in Youth and Young Adults

  Hagar Kandel

  Discusses how neurodiversity combined with gender variance heightens risk of depression and suicide in youth and young adults.

  Child & AdolescentDiverse & Underserved PopulationsSuicide & Self-Harm

• SymposiumThe Complex Landscape of Depression in Neurodiverse and Gender-Variant Youth: From Chronology to Novel Interventions

  Usman Ghumman · Mohammad Ghaziuddin · Mai Uchida · Hagar Kandel · Rana Elmaghraby

  Symposium on how depression presents and is managed in neurodiverse and gender-variant youth, covering its course over time and newer intervention approaches.

  Autism & Neurodevelopmental DisordersChild & AdolescentDiverse & Underserved Populations

• LectureTreating Anxiety and Depression in Autism: Are SSRIs Helpful?

  Roma Vasa

  Considers whether SSRIs help treat anxiety and depression in people with autism.

  Anxiety DisordersAutism & Neurodevelopmental DisordersChild & Adolescent

See all 72 depression sessions at this meeting →

APNA 40th Annual Conference

October 28–31, 2026 · Phoenix, AZ

• LectureDo No Harm: A Safer Approach to Deprescribing Antidepressants

  Lisa Patterson

  Distinguishes antidepressant withdrawal from relapse and introduces hyperbolic tapering for safer discontinuation. Pharmacology-eligible.

  Deprescribing & Polypharmacy

• LectureStrength in Stimulation: Advancing Wellness Through rTMS as an Innovative Treatment for Depression

  Kateleen Collins · Natalie Ramirez · Kenneth Pierce

  Reviews rTMS evidence and shows how multidisciplinary teams can expand neuromodulation access in acute settings.

  Neuromodulation (ECT, TMS)

• LectureMenopause: Recognizing Hormonal Influences in Psychiatric Care

  Staci Burrell

  Strategies for assessing and managing menopause-related mood changes with hormone-informed psychiatric interventions.

  Perinatal & Women's Mental Health

NEI Fall Congress 2026

November 5–8, 2026 · Colorado Springs, CO

• WorkshopThe Fate of Orexins: Their Expanding Role in Insomnia, Hypersomnia, and Depression

  Covers orexin system physiology and the growing therapeutic role of orexin receptor antagonists and agonists across insomnia, hypersomnia, and mood disorders.

  Neuroscience & MechanismsSleep & Insomnia

• SymposiumSwitching Gears in MDD: When, Why, and How to Use Glutamatergic Therapies to Optimize Functional Outcomes

  Andrew J. Cutler · Kristian Dambrino

  When and how to deploy glutamatergic agents in major depressive disorder to improve functional recovery.

  Ketamine & Esketamine

• SymposiumEfficacy, Acceptability, and Accessibility and Accessibility of SDA-PAs: Shared Decision Making in the Selection and Sequencing of Treatments for MDD

  Roger S. McIntyre · Thomas L. Schwartz

  Applies shared decision-making to selecting and sequencing serotonin-dopamine activity partial agonists among MDD treatment options. Title reproduced exactly as published on the agenda.

  Antipsychotic Prescribing

• SymposiumHormones Gone Wild? Depression Across the Female Lifespan From Puberty to Perimenopause

  Jennifer Payne

  Examines hormonally influenced depression across reproductive stages from puberty through perimenopause.

  Perinatal & Women's Mental Health

AAAP 37th Annual Meeting and Scientific Symposium

November 12–15, 2026 · Memphis, TN

• PosterMethadone Effect on Mood Compared to Other Opioid Agonist Therapies in Patients with Opioid Prescriptions: A Systematic Literature Review and Meta-Analysis

  Alyssa Xiong

  Meta-analysis of mood effects of methadone versus other opioid agonist therapies.

  Opioid Use Disorder

• PosterPsilocybin Use, Mental Health Treatment Utilization, and Unmet Treatment Need Among US Individuals with Depression

  Avery Eun

  Psilocybin use and treatment gaps among US adults with depression.

  Psychedelics

NPA 32nd Annual Psychopharmacology Update 2027

February 10–13, 2027 · Las Vegas, NV

• LectureWomen's Health and Cycle-Linked Mood Disorders

  C. Neill Epperson

  Evaluation and management of mood disorders linked to the menstrual cycle, including premenstrual exacerbations and PMDD.

  Perinatal & Women's Mental Health

• LectureThe Menopause Transition: Mood and Anxiety

  Claudio N. Soares

  Mood and anxiety symptoms during perimenopause and menopause, with hormonal and psychopharmacologic treatment options.

  Anxiety DisordersPerinatal & Women's Mental Health

• LectureAccelerated Neuromodulation in the Treatment of Depression

  Scott Aaronson

  Accelerated TMS protocols and other rapid-acting neuromodulation strategies for depression.

  Neuromodulation (ECT, TMS)

• LectureTreating Anxiety in Patients with Depression and Bipolar Disorder

  Mark Zimmerman

  Managing comorbid anxiety in mood disorders, where standard anxiolytic strategies can complicate treatment.

  Anxiety DisordersBipolar Disorder

• LectureTreatment of Mood Disorders in Children and Adolescents

  Manpreet K. Singh

  Current approaches to treating depression and bipolar disorder in youth.

  Bipolar DisorderChild & Adolescent

See all 6 depression sessions at this meeting →

Substance Use Disorders: A Comprehensive Review and Update 2027

February 15–17, 2027 · Lake Buena Vista, FL

• LectureAnxiety & Mood

  Vinod Rao

  Addresses anxiety and mood disorders co-occurring with alcohol use disorder.

  Alcohol Use DisorderAnxiety Disorders

39th ECNP Congress

October 10–13, 2026 · Munich, Germany

• SymposiumS03 – Breaking Hot Topic Symposium – showcasing the timeliest science – Altered immune function in psychiatric disorders and their treatment

  Boris B. Quednow · Sinead King · Jenny Borkent · Anthony Vernon · Cynthia Fu

  Late-breaking findings on immune dysfunction in psychiatry, including the MEMOCYCLINE trial, microbiome-guided treatment, and immune-ageing phenotypes of depression.

  Inflammation & ImmunopsychiatryDrug Pipeline & Clinical Trials

• SymposiumS08 – Speech, digital phenotyping, and artificial intelligence in understanding and predicting trajectories and upcoming episodes in affective disorders

  Dominic Oliver · Vera Ludwig · Srinivasan Vairavan · Maria Faurholt-Jepsen

  NLP on health records, smartphone-based phenotyping, and machine learning to predict mood episodes and classify affective disorders.

  Bipolar DisorderDigital Psychiatry & AI

• SymposiumMS01 – Mini Symposium – Amyloid- and tau-PET biomarkers in late life depression: an update

  Willemijn Jansen · Mathieu Vandenbulcke

  PET biomarkers of amyloid, tau, and synaptic density in geriatric depression, including the Leuven L3D study.

  Dementia & Cognitive DisordersGeriatricNeuroscience & Mechanisms

• SymposiumMS02 – Proof-of-concept studies showcasing biomarker potential

  Leanne Williams · Daniel Gehrlach

  Stratified precision-medicine trials, including an alpha-2a agonist for the cognitive biotype of depression and phase 2 results for the vasopressin 1b antagonist nelivaptan.

  Pharmacogenomics & Precision PsychiatryDrug Pipeline & Clinical Trials

• SymposiumS12 – New Findings Symposium

  A. Coen Coomans · Bengisu Aksoy · Maja Friedemann · Edoardo Pisa · Minh Nguyen · Laura Costantini

  Six short talks on brand-new findings, from personalized rTMS targets in OCD to glymphatic function in depression and transcranial ultrasound stimulation.

  Neuromodulation (ECT, TMS)OCD & Related Disorders

WCP 2026 — 26th World Congress of Psychiatry

September 23–26, 2026 · Stockholm, Sweden

• SymposiumPrecision Psychiatry Advances in the Biological Understanding and Clinical Management of Mood Disorders

  Bipolar DisorderPharmacogenomics & Precision Psychiatry

• SymposiumState of the Art Symposium 03: Complex Clinical Presentations in Mood and Related Disorders

  Bipolar Disorder

• DebateDebate: ADHD - Adjunctive Stimulant for Depression Treatment – Pro-con?

  ADHDStimulants & ADHD Medications

Psych Congress 2026

September 15–19, 2026 · New Orleans, LA

• SymposiumRethinking Pediatric Depression: Early Identification and Emerging Treatments

  Adelaide S. Robb · Julie Carbray · Liv Lewis

  Reviews atypical presentations of youth depression and newer options including rapid-acting agents and digital therapeutics, with strategies for early detection in schools and primary care and a lived-experience perspective.

  Child & AdolescentDigital Psychiatry & AI

• SymposiumSolving Clinical Challenges: Managing Major Depressive Disorder When First-Line Treatments Fall Short

  Brittany Albright · Rebecca Barbee · Kristian Dambrino

  Case-based walkthrough of evaluating apparent treatment resistance in MDD — uncovering hidden contributors like anxiety, trauma, and medical illness — and choosing among optimization, augmentation, and switching pathways.

  Treatment-Resistant Depression

• SymposiumMasterClass: Across Mood Episodes and Throughout the Lifespan: Atypical Antipsychotic Strategies for MDD and Bipolar Disorder

  Gregory Mattingly · Desiree Matthews

  Case-driven review of selecting atypical antipsychotics across mood episodes, weighing efficacy, tolerability, adherence, and patient-specific factors.

  Antipsychotic PrescribingBipolar Disorder

• SymposiumMasterClass: The Road to Recovery in MDD: From Partial Response to Remission and Beyond

  Christoph U. Correll · Brooke Kempf

  Focuses on recognizing clinically meaningful residual depressive symptoms and using adjunctive pharmacologic options to push partial responders toward remission and sustained recovery.

  Novel Antidepressants

• SymposiumLatest Discoveries & Emerging Trends in MDD

  Rakesh Jain · Michael Thase

  Year-in-review of depression research spanning neurobiology, trial results, and pharmacologic and non-pharmacologic innovation, with selected poster presenters showcasing new data.

  Neuroscience & MechanismsDrug Pipeline & Clinical Trials

See all 10 depression sessions at this meeting →